These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8809670)

  • 1. Glucocorticoid resistant syndromes--molecular basis and clinical presentations.
    Brönnegård M; Stierna P; Marcus C
    J Neuroendocrinol; 1996 Jun; 8(6):405-15. PubMed ID: 8809670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of glucocorticoid-resistant syndromes.
    Werner S; Brönnegård M
    Steroids; 1996 Apr; 61(4):216-21. PubMed ID: 8733004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies.
    Moalli PA; Rosen ST
    Leuk Lymphoma; 1994 Nov; 15(5-6):363-74. PubMed ID: 7873993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene.
    Huizenga NA; de Lange P; Koper JW; de Herder WW; Abs R; Kasteren JH; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 2000 May; 85(5):2076-81. PubMed ID: 10843199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.
    Ruiz M; Lind U; Gåfvels M; Eggertsen G; Carlstedt-Duke J; Nilsson L; Holtmann M; Stierna P; Wikström AC; Werner S
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):363-71. PubMed ID: 11589680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin.
    Bamberger CM; Wald M; Bamberger AM; Schulte HM
    Mol Cell Endocrinol; 1997 Aug; 131(2):233-40. PubMed ID: 9296382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
    Chatterjee VK; Madison LD; Mayo S; Jameson JL
    Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms.
    Charmandari E; Kino T; Chrousos GP
    Ann N Y Acad Sci; 2004 Jun; 1024():168-81. PubMed ID: 15265781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant.
    Ramos RA; Meilandt WJ; Wang EC; Firestone GL
    FASEB J; 1999 Jan; 13(1):169-80. PubMed ID: 9872941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of steroid regulation of the MMTV promoter in a small cell lung cancer cell line is caused by a DNA sequence flanking the glucocorticoid response element.
    Huynh TT; Ray DW; Brogan IJ; Stevens A; Davis JR; White A; White A
    J Endocrinol; 2002 Feb; 172(2):295-302. PubMed ID: 11834447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue glucocorticoid resistance/hypersensitivity syndromes.
    Kino T; De Martino MU; Charmandari E; Mirani M; Chrousos GP
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):457-67. PubMed ID: 12943736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
    Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
    Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticosteroid resistance in humans. Elucidation of the molecular mechanisms and implications for pathophysiology.
    Stratakis CA; Karl M; Schulte HM; Chrousos GP
    Ann N Y Acad Sci; 1994 Nov; 746():362-74; discussion 374-6. PubMed ID: 7825890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
    Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue- and context-dependent modulation of hormonal sensitivity of glucocorticoid-responsive genes by hexamethylene bisacetamide-inducible protein 1.
    Shimizu N; Yoshikawa N; Wada T; Handa H; Sano M; Fukuda K; Suematsu M; Sawai T; Morimoto C; Tanaka H
    Mol Endocrinol; 2008 Dec; 22(12):2609-23. PubMed ID: 18801933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes.
    Kino T; Chrousos GP
    J Endocrinol; 2001 Jun; 169(3):437-45. PubMed ID: 11375113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
    Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids.
    Kino T
    Horm Metab Res; 2007 Jun; 39(6):420-4. PubMed ID: 17578758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
    Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.